The second session of the Committee Channel was held to talk about the digital transformation of t

Mondo Technology Updated on 2024-03-08

The *** group of this newspaper Guo Jichuan, Zhang Min, Zhou Shangdian.

On March 7, the second session of the Second Session of the 14th National Committee of the Chinese People's Political Consultative Conference (CPPCC) was held in the Great Hall of the People. Huang Baorong, member of the National Committee of the Chinese People's Political Consultative Conference and deputy director of the Gansu Provincial Department of Industry and Information Technology, and Tang Xudong, member of the National Committee of the Chinese People's Political Consultative Conference and director of the Department of Spleen and Stomach Diseases of Xiyuan Hospital of the China Academy of Chinese Medical Sciences, respectively, accepted an interview with the reporter on topics such as the upgrading and transformation of traditional industries, the investment attraction of the "Eastern Data and Western Computing" project, and the research and development of traditional Chinese medicine.

Huang Baorong: Accelerate the upgrading and transformation of traditional industries and let "old trees sprout".

Gansu is an old industrial base, Huang Baorong said on the "committee channel" that a strong economy must be strong industry, we adhere to the "strong leader, supplement the chain, gather the group", in-depth implementation of the "leading, strong, leading" action, in order to undertake industrial transfer to grasp the investment, vigorously promote the construction of a modern industrial system, and develop new quality productivity in accordance with local conditions. We are focusing on building an important new energy and new energy equipment manufacturing base and new material base in the country, and now walking in the Hexi Corridor, you can see continuous wind power and photovoltaic power stations everywhere, by accelerating the upgrading and transformation of traditional industries, promoting the digital transformation of the industry, and letting "old trees sprout new sprouts".

Huang Baorong gave an example in an interview with the reporter that the Institute of Modern Physics in Lanzhou was founded in 1957 and will completely independently develop China's first set of high-end medical equipment heavy ion accelerator in 2023. There are many such long-established research institutes and large enterprises in Gansu, and they are facing the challenges of digital transformation, and we propose to promote high-end, intelligent and green development, as well as accelerate the digital transformation of local small and medium-sized enterprises, and do a good job in the integration of data and reality.

The picture shows Huang Baorong being interviewed by ** reporter. Photo by Guo Jichuan.

Gansu is one of the eight hub nodes of the "Eastern Data and Western Computing" project, in terms of attracting enterprises to invest in Gansu, Huang Baorong said that Gansu has abundant green power resources, and fully promotes Longdian into Shandong, Longdian into Zhejiang, and Longdian into Shanghai, and is moving from a "large province" to a "strong province". For data center enterprises, the layout in Gansu can obtain the support of green power resources and reduce the production and operating costs of enterprises.

Huang Baorong said: "We are also developing industries with new energy characteristics, promoting the upgrading and transformation of traditional industries, such as introducing green electricity hydrogen production projects, stepping up the cultivation and expansion of emerging industries, and looking forward to the layout of future industries." ”

Tang Xudong: The innovation of traditional Chinese medicine ushered in "time, place, and people".

In the past ten years, China has made a series of major decisions and deployments on the traditional Chinese medicine industry, and at the beginning of last year, the General Office issued the "Implementation Plan for Major Projects for the Revitalization and Development of Traditional Chinese Medicine", which has effectively promoted the inheritance, innovation and high-quality development of traditional Chinese medicine. After the end of the "committee channel", Tang Xudong accepted an interview with the reporter. He said that at present, the innovation and development of traditional Chinese medicine has ushered in a good era of "time, place, and harmony".

The picture shows Tang Xudong being interviewed by the reporter after the end of the "committee channel". Photo by Xu Jiashuo.

Tang Xudong introduced that China greatly encourages the innovation of traditional Chinese medicine, and in 2019, the "Opinions of the Communist Party of China on Promoting the Inheritance, Innovation and Development of Traditional Chinese Medicine" proposed to formulate regulations on the review and approval of traditional Chinese medicine, and implement a priority review and approval system based on clinical value. Since then, the State Food and Drug Administration has established an evidence system for the registration and review of traditional Chinese medicine based on the "three combinations" of traditional Chinese medicine theory, human experience and clinical trials, and encouraged the use of traditional Chinese medicine research methods and modern science and technology to research and develop traditional Chinese medicine.

Tang Xudong said that traditional Chinese medicine companies should seize this good opportunity to continuously promote the research and development of new drugs on the market, so that enterprises have better long-term development space. The industrialization of the field of traditional Chinese medicine is progressing rapidly, and in the case of having good production equipment and talent gathering, we should actively invest funds to promote the research and development of new traditional Chinese medicine.

For the R&D model of traditional Chinese medicine, in addition to the R&D model of chemical drugs, Tang Xudong suggested that we should vigorously promote the R&D model of traditional Chinese medicine compounds, and develop excellent Chinese patent medicines with good marketing value and combination of disease and syndrome for dominant diseases based on the clinical experience of traditional Chinese medicine.

* |Station cool Hailuo production |Zhang Wenling review |Edited by Su Shiyu |Sun Qian's final review |Ma Fangye

Related Pages